PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Aldara (Imiquimod)- FDA 36 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 2 0.03 -0.97 0.06 0.77
Abilify (Aripiprazole)- FDA 71 Drug Drug Adalimumab (Humira)- FDA 62 1 0.02 -0.98 0.02 0.77
Adalimumab (Humira)- FDA 62 Drug Drug Aripiprazole (Abilify)- FDA 71 1 0.02 -0.98 0.02 0.77
Hypertriglyceridemia 7,877 Disease Disease Dyslipidemia 15,225 910 0.08 -0.91 0.12 0.77
CXCL11 526 Target Target CCL1 220 11 0.03 -0.96 0.05 0.77
Gonorrhea 5,642 Disease Disease Syphilis 20,217 1,110 0.10 -0.87 0.20 0.77
Genital Warts 1,791 Disease Disease Genital Herpes 2,660 104 0.05 -0.95 0.06 0.77
Sunburn 1,669 Disease Disease Skin Cancer 11,561 443 0.10 -0.84 0.27 0.77
Multidrug Resistance-Associated Protein 2 462 Target Target Multidrug Resistance Protein 1 495 13 0.03 -0.97 0.03 0.77
Adalimumab (Humira)- FDA 62 Drug Drug Acetaminophen (Tylenol)- FDA 69 1 0.02 -0.98 0.02 0.77
BAFFR 44 Target Target BLyS 457 6 0.04 -0.92 0.14 0.77
Abacavir Sulfate (Ziagen)- FDA 61 Drug Drug Acetaminophen (Tylenol)- FDA 69 1 0.02 -0.98 0.02 0.77
Acyclovir for Injection (Zovirax Injection)- FDA 3 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 1 0.04 -0.81 0.33 0.77
CXCL9 1,016 Target Target CCL8 197 21 0.05 -0.94 0.11 0.77
Septic Arthritis 4,121 Disease Disease Osteomyelitis 17,273 877 0.10 -0.86 0.21 0.77
CCL18 256 Target Target CXCL7 76 4 0.03 -0.97 0.05 0.77
CXCL9 1,016 Target Target CCL21 808 32 0.04 -0.96 0.04 0.77
Deep Vein Thrombosis 10,952 Disease Target D-Dimer 6,185 630 0.08 -0.92 0.10 0.77
CXCL11 526 Target Target CXCL2 750 21 0.03 -0.97 0.04 0.77
Kappa-Type Opioid Receptor 4 Target Target Sphingosine 1-Phosphate Receptor 1 150 1 0.04 -0.86 0.25 0.77
BAFFR 44 Target Target CD148 74 1 0.02 -0.98 0.02 0.77
Atorvastatin Calcium (Lipitor)- FDA 28 Drug Drug Acetic Acid (Acetic Acid)- FDA 168 2 0.03 -0.96 0.07 0.77
CD1A 2,739 Target Target CD14 9,941 456 0.09 -0.89 0.17 0.77
Alpha-Glucosidase 4,319 Target Target Alpha-Amylase 7,171 376 0.07 -0.93 0.09 0.77
Hypertriglyceridemia 7,877 Disease Disease Hyperlipidemia 15,317 960 0.09 -0.91 0.12 0.77
Tinea 3,909 Disease Disease Ringworm 880 129 0.07 -0.91 0.15 0.77
CCL18 256 Target Target CXCL3 145 5 0.03 -0.97 0.03 0.77
DNAJB1 44 Target Target CXCL3 145 2 0.03 -0.97 0.05 0.77
ELC 355 Target Target DC-CK1 22 4 0.05 -0.90 0.18 0.77
Drug Hypersensitivity 902 Disease Drug Abacavir 1,496 50 0.04 -0.96 0.06 0.77
CCL7 274 Target Target CXCL9 1,016 24 0.05 -0.94 0.09 0.77
CCL19 658 Target Target CXCL11 526 19 0.03 -0.97 0.04 0.77
CXCL10 2,386 Target Target CCL8 197 52 0.08 -0.85 0.26 0.77
Chronic Lymphocytic Leukemia 11,642 Disease Disease Leukemia 162,805 11,642 0.27 -0.01 1.00 0.77
CXCL16 341 Target Target CXCL9 1,016 26 0.04 -0.95 0.08 0.77
Hypoglycemia 20,698 Disease Disease Hyperglycemia 28,168 2,394 0.10 -0.90 0.12 0.77
Cryptococcosis 3,853 Disease Disease Histoplasmosis 4,583 241 0.06 -0.94 0.06 0.78
Avastin (Bevacizumab)- FDA 207 Drug Drug Arzerra (Ofatumumab Injection)- FDA 1 1 0.07 -0.71 1.00 0.78
Diabetes Mellitus Type 1 683 Disease Disease Diabetes Mellitus Type 2 1,311 42 0.04 -0.95 0.06 0.78
CAPG 85 Target Target DJ-1/PARK7 21 1 0.02 -0.97 0.05 0.78
CCL5 2,002 Target Target CCL8 197 45 0.07 -0.87 0.23 0.78
Abilify (Aripiprazole)- FDA 71 Drug Drug Accutane (Isotretinoin)- FDA 39 1 0.02 -0.98 0.03 0.78
Aripiprazole (Abilify)- FDA 71 Drug Drug Accutane (Isotretinoin)- FDA 39 1 0.02 -0.98 0.03 0.78
Major Depressive Disorder 12,517 Disease Disease Anxiety Disorder 8,985 855 0.08 -0.92 0.10 0.78
CCL4 5,638 Target Target CCL2 3,560 295 0.07 -0.93 0.08 0.78
CXCL7 76 Target Target CXCL2 750 13 0.05 -0.90 0.17 0.78
Acetaminophen (Tylenol)- FDA 69 Drug Drug Accutane (Isotretinoin)- FDA 39 1 0.02 -0.98 0.03 0.78
C5a 4,164 Target Target C4A 1,177 161 0.07 -0.91 0.14 0.78
Abciximab (ReoPro)- FDA 7 Drug Drug Alteplase (Activase)- FDA 112 1 0.04 -0.92 0.14 0.78
Abciximab (ReoPro)- FDA 7 Drug Drug Activase (Alteplase)- FDA 112 1 0.04 -0.92 0.14 0.78